1. Home
  2. IMNN vs WETH Comparison

IMNN vs WETH Comparison

Compare IMNN & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • WETH
  • Stock Information
  • Founded
  • IMNN 1982
  • WETH 1992
  • Country
  • IMNN United States
  • WETH China
  • Employees
  • IMNN N/A
  • WETH N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • IMNN Health Care
  • WETH
  • Exchange
  • IMNN Nasdaq
  • WETH Nasdaq
  • Market Cap
  • IMNN 12.9M
  • WETH 10.9M
  • IPO Year
  • IMNN 1985
  • WETH N/A
  • Fundamental
  • Price
  • IMNN $5.33
  • WETH $1.49
  • Analyst Decision
  • IMNN Buy
  • WETH
  • Analyst Count
  • IMNN 2
  • WETH 0
  • Target Price
  • IMNN $182.61
  • WETH N/A
  • AVG Volume (30 Days)
  • IMNN 153.1K
  • WETH 245.1K
  • Earning Date
  • IMNN 11-06-2025
  • WETH 11-13-2025
  • Dividend Yield
  • IMNN N/A
  • WETH N/A
  • EPS Growth
  • IMNN N/A
  • WETH N/A
  • EPS
  • IMNN N/A
  • WETH 0.71
  • Revenue
  • IMNN N/A
  • WETH $42,692,692.00
  • Revenue This Year
  • IMNN N/A
  • WETH N/A
  • Revenue Next Year
  • IMNN N/A
  • WETH N/A
  • P/E Ratio
  • IMNN N/A
  • WETH $1.96
  • Revenue Growth
  • IMNN N/A
  • WETH 6.48
  • 52 Week Low
  • IMNN $4.70
  • WETH $0.76
  • 52 Week High
  • IMNN $41.22
  • WETH $2.85
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 47.96
  • WETH 70.23
  • Support Level
  • IMNN $5.04
  • WETH $1.16
  • Resistance Level
  • IMNN $5.55
  • WETH $1.77
  • Average True Range (ATR)
  • IMNN 0.29
  • WETH 0.15
  • MACD
  • IMNN 0.04
  • WETH 0.00
  • Stochastic Oscillator
  • IMNN 70.94
  • WETH 48.30

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: